This report is based on insights gathered during the European Venom Network (EUVEN) workshop on the patentability of natural compounds, with a focus on venom-derived molecules, held online on June 10, 2022. The program explored key aspects of intellectual property (IP) rights relevant to the development of therapeutic agents derived from natural sources, including animal venoms and toxins. Topics included intellectual property considerations in biotechnology, strategies for creating and managing intellectual property portfolios, and licensing pathways from academic research to industry. The review further analyzes the specific challenges and opportunities of patenting venom-based compounds and outlines best practices for sharing intellectual property within collaborative research consortia such as EUVEN. Finally, it incorporates industry perspectives on fostering academic partnerships to advance the translational potential of venom-derived therapies. This document aims to serve as a practical guide for researchers at all career stages working in the life sciences, particularly those involved in the discovery and development of innovations based on natural products.
#guide #biological #science #researchers
